BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update
BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update
BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average daily volume of 47,100 shares, the days-to-cover ratio is presently 1.2 days.
7月份，新浪空头股数的股价大幅下跌。截至7月15日，空头股数共有57,100股，较6月30日的71,800股下降20.5%。以日均成交量47,100股计算，目前天数与回补比率为1.2天。
BetterLife Pharma Stock Performance
BetterLife Pharma股票表现
BetterLife Pharma stock opened at $0.11 on Tuesday. BetterLife Pharma has a 52-week low of $0.05 and a 52-week high of $0.30. The firm has a 50 day moving average price of $0.09 and a two-hundred day moving average price of $0.12.
BetterLife Pharma的股票周二开盘报0.11美元。BetterLife Pharma的52周低点为0.05美元，52周高位为0.30美元。该公司的50日移动均线价格为0.09美元，200日移动均线价格为0.12美元。
BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last released its quarterly earnings results on Tuesday, June 28th. The company reported ($0.03) earnings per share (EPS) for the quarter.
BetterLife Pharma(OTCMKTS：BETRF-GET Rating)最近一次发布季度收益报告是在6月28日(星期二)。该公司公布了该季度每股收益(EPS)(0.03美元)。
BetterLife Pharma Company Profile
BetterLife制药公司简介
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
BetterLife制药公司是一家生物技术公司，在加拿大和国际上从事治疗神经疾病的化合物的开发和商业化。它参与从一系列基于干扰素的互补技术中提炼和开发候选药物，这些技术有可能让免疫系统参与抗击病毒感染。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
- Green Your Portfolio With These Stocks
- Bloomin' Brands Is Blossoming
- Is it Time to Cash Out of Signet Jewelers Stock?
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- Deep Value High Yield Newell Brands Is Ready To Bottom
- 免费获取StockNews.com关于BetterLife Pharma的研究报告(BETRF)
- 用这些股票来保护你的投资组合
- 百花齐放的品牌正在盛开
- 现在是套现Signet珠宝商股票的时候了吗？
- MarketBeat播客：寻找2022年剩余时间的投资机会
- 深度价值高收益纽威尔品牌已准备好触底
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
接受BetterLife Pharma Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对BetterLife Pharma和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。